VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shot up 11.8% during mid-day trading on Thursday . The company traded as high as C$0.20 and last traded at C$0.19. 312,200 shares were traded during mid-day trading, an increase of 241% from the average session volume of 91,579 shares. The stock had previously closed at C$0.17.
VentriPoint Diagnostics Stock Performance
The stock has a market cap of C$29.08 million, a P/E ratio of -6.17 and a beta of 0.41. The firm’s 50-day moving average is C$0.18 and its two-hundred day moving average is C$0.21. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of 217.41.
About VentriPoint Diagnostics
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
Read More
- Five stocks we like better than VentriPoint Diagnostics
- Election Stocks: How Elections Affect the Stock Market
- 3 Small-Cap Stocks on the Way to Bigger and Better Days
- Where Do I Find 52-Week Highs and Lows?
- MarketBeat Week in Review – 9/30 – 10/4
- Bank Stocks – Best Bank Stocks to Invest In
- Top Streaming Companies: Who’s Winning the Battle?
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
